Part, Chapter, Paragraph
1 II, 5. 5. 3| Traficante R, Reid WG, O’Sullivan DJ, Williamson PM (1999): The
2 II, 5. 5. 3| McCrone P, Allcock LM, Burn DJ (2007): Predicting the cost
3 II, 5. 6. 6| Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey
4 II, 5. 6. 6| 148-153~Spector TD, Hart DJ, and Leedham-Green M (1991):
5 II, 5. 6. 6| S171~ ~Spector TD, Hart DJ, Powell RJ (1993): Prevalence
6 II, 5. 6. 6| Chaussade S, Cucinotta D, Veale DJ, Martin-Mola E (2004): Musculoskeletal
7 II, 5. 7. 7| Stevens PE, O'donoghue DJ, de LS, Van VJ, Klebe B,
8 II, 5. 8. 7| 185.~ ~Kriegsman DM, Deeg DJ, Stalman WA (2004): Comorbidity
9 II, 5. 11. 7| 1–72~ ~Kay J, Gawkrodger DJ, Mortimer MJ et al (1994):
10 II, 5. 15. 6| Lilitkarntakul P, Webb DJ (2006): Are rare diseases
11 II, 9. 1. 1| Draper ES, Manktelow B, Field DJ, James D (1999): Prediction
12 II, 9. 3. 2| Draper ES, Manktelow B, Field DJ, James D (1999): Prediction
13 III, 10. 2. 1| available at: htt ~ ~Collins DJ, Lapsley HM (200): Counting
14 III, 10. 2. 4| Med, 4:844-847.~ ~Lehmann DJ, Cortina-Borja M, Warden
